Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Elacestrant is indicated for the treatment of postmenopausal women or adult men with estrogen receptor (ER)-positive malignant tumors.Precautions for Elacestrant UseDyslipidemiaAmo···【more】
Article source：Captain MedicineRelease date：2026-02-02Recommended：312
Anagrelide is indicated to reduce the risk of blood clots in patients with thrombocythemia (an abnormally high platelet count in the blood). Its mechanism of action is to inhibit p···【more】
Article source：Captain MedicineRelease date：2026-01-30Recommended：290
Special caution is required when using anagrelide, as certain drugs may interact with it.What are the drug interactions of Anagrelide?Do not take this medicine with cisapride, dron···【more】
Article source：Captain MedicineRelease date：2026-01-30Recommended：277
Anagrelide may cause a range of side effects during use.What side effects may Anagrelide cause?Inform your doctor promptly if you experience any of the following symptoms that are ···【more】
Article source：Captain MedicineRelease date：2026-01-30Recommended：266
Anagrelide is used to reduce the platelet count in patients with myeloproliferative disorders (platelets are blood cells required for controlling bleeding).What is Anagrelide?Patie···【more】
Article source：Captain MedicineRelease date：2026-01-30Recommended：305
Revumenib (Revuforj) is an oral, first-in-class targeted Menin protein inhibitor indicated for the treatment of relapsed or refractory acute leukemia with specific genetic abnormal···【more】
Article source：Captain MedicineRelease date：2026-01-29Recommended：360
Revumenib (trade name: Revuforj) is an oral, first-in-class targeted Menin inhibitor indicated for the treatment of relapsed or refractory acute leukemia with KMT2A gene rearrangem···【more】
Article source：Captain MedicineRelease date：2026-01-29Recommended：294
Revumenib (trade name: Revuforj) is an oral targeted drug of the Menin inhibitor class, indicated for the treatment of relapsed or refractory acute leukemia with KMT2A gene rearran···【more】
Article source：Captain MedicineRelease date：2026-01-29Recommended：400
Revuforj carries a risk of differentiation syndrome, and patients and their family members should be alert to relevant symptoms during treatment.Precautions for Revuforj Administra···【more】
Article source：Captain MedicineRelease date：2026-01-29Recommended：373
Rivimeinib is available in three tablet strengths: 25 mg, 110 mg, and 160 mg.What are the side effects of Rivimeinib (Revuforj)?The most common side effects of Revuforj include ble···【more】
Article source：Captain MedicineRelease date：2026-01-28Recommended：282
Combination of this class of drugs with Revuforj is not recommended; if co-administration is unavoidable, healthcare providers will need to monitor you more frequently for QTc inte···【more】
Article source：Captain MedicineRelease date：2026-01-28Recommended：316
Remission is the primary treatment goal for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).How effective is Revuforj for treatment?Approximately one in five pa···【more】
Article source：Captain MedicineRelease date：2026-01-28Recommended：377
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：8572025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：10572024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended：3502026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：4262026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：6242026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：6102026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：4792026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：6252026-31-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
